β€ AHA: HYPERTENSION & GUT MICROBIOME π¦
This American Heart Association (AHA) Science Advisory explores the emerging link between Gut Microbiome composition and the regulation of Blood Pressure.
- Research indicates that an imbalance of intestinal bacteria, or Gut Dysbiosis, contributes to increasing Hypertension levels.
- Hypertension is a major health crisis that significantly increases the risk of heart failure and kidney disease.
Despite advancements, 15% to 20% of patients suffer from Treatment-Resistant Hypertension, which persists even when using three or more classes of medication.
- This advisory examines how an imbalanced Gut Microbiome acts as a NON-CONVENTIONAL RISK FACTOR and a novel opportunity for therapeutic intervention.
Evidence confirms that gut DYSBIOSIS elevates blood pressure by disrupting the gut barrier and activating the immune system.
- Mechanistic studies show that transplanting microbes from hypertensive humans into rodents can induce high blood pressure in the recipients, proving a CAUSAL LINK.
- High SALT intake is a primary complicating factor that depletes beneficial bacteria like Lactobacillus. This depletion leads to increased inflammation and the suppression of essential metabolites, such as Short-Chain Fatty Acids (SCFA), which normally help the body maintain healthy blood pressure levels.
- Clinical trials show that interventions like INTERMITTENT FASTING can improve blood pressure by altering the metabolic potential of the Gut.
In a targeted trial, Prebiotic supplements that deliver short-chain fatty acids (SCFA) directly to the colon reduced Systolic Blood Pressure by 6.1 mm Hg.
* Below is an Image showing the impact of Microbiome Interventions and their Clinical Impact on Systolic Blood Pressure (SBP).
- The antibiotic Minocycline has also shown success in lowering blood pressure by reducing inflammation and shifting gut microbial profiles.
Furthermore, fecal microbiota transplantation (FMT) is being explored as a direct strategy to replace a hypertensive microbiome with microbes from healthy donors.
- The advisory concludes that the GUT MICROBIOME is a vital therapeutic target for HYPERTENSION management. Future research must identify specific bacterial strains and functional changes to facilitate rapid translation into clinical practice.
......CONTINUE READING THE FULL SUMMARY FOR FREE AT π
β
π Link to the AHA Scientific Advisory ππ https://precarmed.substack.com/p/hypertension-and-gut-microbiome-aha
π½Β Please Read the Note BelowΒ π
π― SUBSCRIBE FOR FREE in our Trusted Open Version >
JUST CLICK HERE π
π₯ Join us in contributing to the dissemination of knowledge and Research with Precarmed Summaries...!!Β
πΒ Your DONATION can make it possible to continue sending you these Summaries directly to your INBOX....π¬Β for FREE....!!Β π¬Β Β Β
